42/67 |
Number of patients/episodes |
45.5 ± 14.3 |
Age, years )episodes) |
28(66.6%)/47(70.1%) |
Female, n (patients/episodes) |
1.72 ± 0.21 |
BSA, m2 (episodes) |
Clinical presentations in episodes |
Clinical presentations in
episodes |
31 (46.3%) |
Dyspnea |
4 (6%) |
Chest pain |
18 (26.8%) |
Significant edema**
|
10 (14.9%) |
Ascites |
12 (17.9%) |
Increased JVP |
2 (3%) |
Hypotension |
15 (22.4%) |
Reduced click |
|
NYHA functional class in episodes |
14 (20.9%) |
I-II |
17 (25.4%) |
III-IV |
Mechanical prosthetic valve in episodes |
Mechanical prosthetic valve in
episodes |
26 (38.8%) |
St. Jude Medical |
24 (35.8%) |
Carbomedics (Standard) |
15 (22.9%) |
Carbomedics (Orbis) |
2 (2.9%) |
Unknown |
31 (27-33) |
Prosthetic valve size***
|
50 (0.4-276) |
Elapsed time from valve surgery,
months***
|
Anticoagulation status |
Anticoagulation status |
2.27 (1.7-3.1) |
Admission INR |
43 (70%) |
Sub-therapeutic INR <3 |
52 (82%) |
Sub-therapeutic INR <3.5 |
48 (71.6%) |
Aspirin use |
TV pathology in patients |
TV pathology in patients |
28 (66.6%) |
RHD |
12 (28.5%) |
CHD |
2 (4.7%) |
IE |
Concomitant valvular surgeries in patients/episodes |
Concomitant
valvular surgeries in patients/episodes |
25 (59.5%)/41 (61.1%) |
MVR |
11 (26.1%)/17 (25.3%) |
AVR |
4 (9.5%)/11(16.4%) |
Redo TVR |
Other comorbidities |
Other comorbidities |
6 (14.3%) |
Hypertension |
2 (4.8%) |
Diabetes mellitus |
1 (2.3%) |
Coronary artery disease |
1 (2.3%) |
Prior cerebrovascular events |
38 (56.7%) |
Atrial fibrillation in episodes |
9 (21.4%) |
Permanent pacemaker in patients |